Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 3Gastrointestinal 2Breast 2Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Head and Neck Neoplasms 2Urogenital Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pheochromocytoma 1Paraganglioma 1Neoplastic Syndromes, Hereditary 1Neoplasms, Unknown Primary 1Kidney Neoplasms 1Digestive System Neoplasms 1Central Nervous System Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Bone Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 6Radiotherapy 3Fluorodeoxyglucose F18 3entrectinib 2IFL protocol 2FAPI-46 2Cisplatin 2Bevacizumab 2tipifarnib 1regorafenib 1pembrolizumab 1fluoromisonidazole 1entinostat 1cc-486 1brodalumab 1alectinib 1aflibercept 1Triiodothyronine 1Trastuzumab 1Thyroxine 1Thiotepa 1Thalidomide 1Tamoxifen 1Ritonavir 1Quality of Life 1Psychology, Positive 1Proton Therapy 1Peripheral Blood Stem Cell Transplantation 1Patient-Specific Modeling 1Patient Reported Outcome Measures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Genetic Testing × Head & Neck × Clear all
NCT04456140 2023-07-24

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

Mayo Clinic

Phase 1 Completed
230 enrolled
BreastCNSGastrointestinalHead & Neck

Brain Neoplasms, Breast Neoplasms, Digestive System Neoplasms, Head and Neck Neoplasms, Neoplasms, Unknown Primary, Urogenital Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡